Full-Time

Molecular Technologist I-IV: Sunday-Wednesday

AM Shift

Posted on 4/30/2024

Tempus

Tempus

1,001-5,000 employees

AI-enabled precision medicine and analytics

AI & Machine Learning
Data & Analytics

Junior

Durham, NC, USA

Requirements
  • MS in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year pertinent clinical laboratory experience with molecular biology
  • BS/BA in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year of pertinent clinical lab experience in molecular biology
  • Excellent communication skills
  • Experience with next-generation sequencing
  • Work in a CLIA/CAP high-complexity laboratory
  • Experience with robotics and automated liquid handling systems
  • Knowledge of LIMS platforms and various computer systems
Responsibilities
  • Perform routine testing, quality control, calibration, maintenance and proficiency testing in accordance with current laboratory procedures
  • Perform complex molecular-based procedures with a high degree of quality and in accordance with established protocols
  • Perform next-generation sequencing, including nucleic acid extraction, DNA/RNA quantification and qualification, NGS library preparation, probe hybridization, probe/library capture, library cleanup and quantification, loading sequencing libraries onto the Illumina Nextseq, HiSeq4000, and Novaseq
  • Sterilizing laboratory equipment and workspaces as assigned
  • Entering clinical patient data into the Laboratory Information Management system
  • Obtain 12 continuing education hours in the field of oncology or molecular biology
  • Maintain competency to perform all assigned molecular biology protocols in accordance with CAP, CLIA, NYSDOH regulations
  • Work the Sunday-Wednesday, AM Shift

Tempus specializes in AI-enabled precision medicine, utilizing data and artificial intelligence to accelerate the discovery of novel targets, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier. The company's analytical machine learning platform leverages expansive clinical and molecular data to enable real-time, data-driven decisions for personalized care and targeted therapies.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

6%

1 year growth

21%

2 year growth

51%